Inspira Technologies Oxy B.H.N. Ltd. (IINN) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Raanana, イスラエル. 現CEOは Dagi Shahar Ben-Noon.
IINN を有する IPO日 2021-07-14, 37 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $12.23M.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
